DESSIALIS CRUZ: Open Payments
NPI 1982920898 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 13 payments from 7 companies in 2025. Trend: 2023 $1,350 · 2024 $1,501 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $254 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Amgen Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| GENZYME CORPORATION | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
Products named: AIRSUPRA, FASENRA, DUPIXENT, NUCALA, TEZSPIRE, REBYOTA, NEFFY.
Industry payments across NY — which companies pay providers there.
